NIAID to Fund Pathogen, Toxin Dx

The $20 million program will support development of tools for NIAID priorities including diagnostics, therapeutics, vaccines, and others.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.